These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36696734)

  • 1. Determination of global chemical patterns in exhaled breath for the discrimination of lung damage in postCOVID patients using olfactory technology.
    Zamora-Mendoza BN; Sandoval-Flores H; Rodríguez-Aguilar M; Jiménez-González C; Alcántara-Quintana LE; Berumen-Rodríguez AA; Flores-Ramírez R
    Talanta; 2023 May; 256():124299. PubMed ID: 36696734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
    Zamora-Mendoza BN; Díaz de León-Martínez L; Rodríguez-Aguilar M; Mizaikoff B; Flores-Ramírez R
    Talanta; 2022 Jan; 236():122832. PubMed ID: 34635222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
    Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
    J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of chemoresistive gas sensors and chemometric analysis to differentiate the fingerprints of global volatile organic compounds from diseases. Preliminary results of COPD, lung cancer and breast cancer.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Pérez-Padilla R; Domínguez-Reyes CA; Tenorio-Torres JA; Ornelas-Rebolledo O; Mehta G; Zamora-Mendoza BN; Flores-Ramírez R
    Clin Chim Acta; 2021 Jul; 518():83-92. PubMed ID: 33766555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of volatile organic compounds in the urine of patients with cervical cancer. Test concept for timely screening.
    Díaz de León-Martínez L; Flores-Ramírez R; López-Mendoza CM; Rodríguez-Aguilar M; Metha G; Zúñiga-Martínez L; Ornelas-Rebolledo O; Alcántara-Quintana LE
    Clin Chim Acta; 2021 Nov; 522():132-140. PubMed ID: 34418363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
    de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
    J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
    Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
    Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-COVID syndrome screening through breath analysis using electronic nose technology.
    V R N; Mohapatra AK; V K U; Lukose J; Kartha VB; Chidangil S
    Anal Bioanal Chem; 2022 May; 414(12):3617-3624. PubMed ID: 35303135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia.
    Tondo P; Scioscia G; Di Marco M; Quaranta VN; Campanino T; Palmieri G; Portacci A; Santamato A; Lacedonia D; Carpagnano GE; Dragonieri S
    Molecules; 2024 Sep; 29(18):. PubMed ID: 39339353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Smell of Hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness.
    Lacey JRN; Kidel C; van der Kaaij JM; Brinkman P; Gilbert-Kawai ET; Grocott MPW; Mythen MG; Martin DS;
    Physiol Rep; 2018 Sep; 6(17):e13854. PubMed ID: 30187693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
    van der Sar IG; Moor CC; Oppenheimer JC; Luijendijk ML; van Daele PLA; Maitland-van der Zee AH; Brinkman P; Wijsenbeek MS
    Chest; 2022 Mar; 161(3):738-747. PubMed ID: 34756945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.